chlorzoxazone has been researched along with Adolescent Obesity in 1 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The impact of obesity-related alterations on drug metabolism and its consequences for drug dosing remains largely unknown in both children and adults." | 2.82 | The CYTONOX trial. ( Christensen, HR; Dalhoff, KP; Gade, C; Holm, JC; Holst, H; Mikus, G, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gade, C | 1 |
| Mikus, G | 1 |
| Christensen, HR | 1 |
| Dalhoff, KP | 1 |
| Holm, JC | 1 |
| Holst, H | 1 |
1 trial available for chlorzoxazone and Adolescent Obesity
| Article | Year |
|---|---|
The CYTONOX trial.
Topics: Adolescent; Caffeine; Child; Chlorzoxazone; Clinical Protocols; Cytochrome P-450 CYP1A2; Cytochrome | 2016 |